Assessment the effects of insulin on adiponectin, nitric oxide, myeloperoxidase and lipid profile in type 1 diabetic patients
Type 1 diabetes (T1DM) is well recognized risk factor cardiovascular disease (CVD). Insulin therapy is recommended for all patients with type 1 diabetes. Previous findings showed that diabetes impairs endothelial function and increased glucose level reduces nitric oxide (NO) output a...
Main Authors: | Jehan A. Mohammad, Zainab H. Fathi, Thikra Ali Allwash |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2021-04-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/63449/download/pdf/ |
Similar Items
-
Evaluation the effects of insulin on oxidant/antioxidant status in type 1 diabetic patients
by: Ammar A. Y. Almulathanon, et al.
Published: (2021-09-01) -
Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis
by: Nursel Dilek, et al.
Published: (2016-12-01) -
The role of myeloperoxidase-derived lipid oxidants in atherosclerosis
by: Dever, Gary James
Published: (2007) -
Lipid peroxidation by myeloperoxidase
by: Henderson, Erron James
Published: (2012) -
Simvastatin Attenuates Contrast-Induced Nephropathy through Modulation of Oxidative Stress, Proinflammatory Myeloperoxidase, and Nitric Oxide
by: Ketab E. Al-Otaibi, et al.
Published: (2012-01-01)